Gene and cell therapy for heart disease

Area of Science:

• Cardiovascular Medicine
• Regenerative Medicine
• Molecular Cardiology

Background:

• Heart disease is a leading cause of mortality, with heart failure representing its end stage.
• Causes include ischemia, hypertension, and coronary artery disease, leading to ventricular remodeling and contractile deficits.
• Diastolic dysfunction affects 30-40% of heart failure patients, while systolic function may be preserved.

Purpose of the Study:

• To review novel therapeutic strategies for heart disease and heart failure.
• To explore gene transfer, therapeutic angiogenesis, and stem cell therapy as potential treatments.
• To highlight advancements in understanding the molecular and cellular basis of heart disease.

Main Methods:

• Review of current research on gene transfer for modulating cardiac contractility.
• Analysis of therapeutic angiogenesis approaches for treating myocardial ischemia.
• Evaluation of embryonic and adult stem cell transfer for replacing damaged heart muscle.

Main Results:

• Gene transfer offers a way to enhance or regulate cardiac contractility.
• Therapeutic angiogenesis aims to restore blood flow to ischemic heart tissue.
• Stem cell therapies show promise for regenerating damaged myocardium.

Conclusions:

• Novel strategies like gene transfer, angiogenesis, and stem cell therapy are under development for heart failure.
• These approaches target molecular and cellular mechanisms to restore heart function.
• Advancements in regenerative medicine offer new hope for treating heart disease.